We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Single-center study demonstrates reduced relapse rates in neuromyelitis optica using anti-CD20 therapy, indicating significant potential benefits.
No takes yet. Share an insight, caveat, or question.
Aninang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: